Literature DB >> 26597272

[Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].

T H C Krüger1, M A Wollmer2, P Negt1, H Frieling1, S Jung1,2, K G Kahl3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26597272     DOI： 10.1007/s00115-015-0028-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  21 in total

1.  Injectable atypical antipsychotics for agitation in borderline personality disorder.

Authors:  J C Pascual; M Madre; J Soler; J Barrachina; M J Campins; E Alvarez; V Pérez
Journal:  Pharmacopsychiatry       Date:  2006-05       Impact factor: 5.788

Review 2.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

3.  The expert consensus guideline series. Treatment of behavioral emergencies 2005.

Authors:  Michael H Allen; Glenn W Currier; Daniel Carpenter; Ruth W Ross; John P Docherty
Journal:  J Psychiatr Pract       Date:  2005-11       Impact factor: 1.325

4.  What do consumers say they want and need during a psychiatric emergency?

Authors:  Michael H Allen; Daniel Carpenter; John L Sheets; Steven Miccio; Ruth Ross
Journal:  J Psychiatr Pract       Date:  2003-01       Impact factor: 1.325

5.  Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.

Authors:  Joseph Kwentus; Robert A Riesenberg; Morteza Marandi; Raymond A Manning; Michael H Allen; Robert S Fishman; Daniel A Spyker; John H Kehne; James V Cassella
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

6.  Cost of borderline personality disorder in Catalonia (Spain).

Authors:  L Salvador-Carulla; M Bendeck; M Ferrer; O Andión; E Aragonès; M Casas
Journal:  Eur Psychiatry       Date:  2014-08-27       Impact factor: 5.361

7.  Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up.

Authors:  Eduardo Martinho; Garrett M Fitzmaurice; Frances R Frankenburg; Mary C Zanarini
Journal:  J Clin Psychopharmacol       Date:  2014-08       Impact factor: 3.153

8.  Absence of evidence that the pro re nata regimen confers benefit: a review of the studies.

Authors:  Kazunari Yoshida; Takefumi Suzuki; Hiroyuki Uchida; Masaru Mimura
Journal:  Int Clin Psychopharmacol       Date:  2013-09       Impact factor: 1.659

9.  [Inhalative loxapine: old tried and trusted medication with new indications].

Authors:  G Juckel
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

10.  The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.

Authors:  Michael P Wilson; David Pepper; Glenn W Currier; Garland H Holloman; David Feifel
Journal:  West J Emerg Med       Date:  2012-02
View more
  2 in total

Review 1.  Patients with Borderline Personality Disorder in Emergency Departments.

Authors:  Untara Shaikh; Iqra Qamar; Farhana Jafry; Mudasar Hassan; Shanila Shagufta; Yassar Islamail Odhejo; Saeed Ahmed
Journal:  Front Psychiatry       Date:  2017-08-04       Impact factor: 4.157

Review 2.  The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.

Authors:  Domenico de Berardis; Michele Fornaro; Laura Orsolini; Felice Iasevoli; Carmine Tomasetti; Andrea de Bartolomeis; Nicola Serroni; Alessandro Valchera; Alessandro Carano; Federica Vellante; Stefano Marini; Monica Piersanti; Giampaolo Perna; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.